The Source Blog
Trends in Price and Quality Transparency
All Payer Claims Databases (APCD)
For more on APCD’s, check out our Legislative Topics: All Payer Claims Databases overview on Medium.
- Key:
- Implementing APCD
- Investigating APCD
Pharmaceutical Price Transparency Legislation
For more on this legislation, refer to our Issue Brief on The Source Blog and the NASHP Center for Rx Pricing.
- Key:
- Price Transparency Legislation
Recent Action in Price and Quality Transparency
SF 19 – Iowa
Introduced: 2019 Status: In Process
A bill for an act relating to the disclosure of the prices charged for health services rendered by health care providers and hospitals.
HF 605 – Iowa
Introduced: 2019 Status: In Process
A bill for an act relating to insurance notices and documents delivered by electronic means to a consumer that purchases portable electronics insurance in a retail transaction. (Formerly HSB 182.)
SF 559 – Iowa
Introduced: 2019 Status: In Process
A bill for an act relating to insurance notices and documents delivered by electronic means to a consumer that purchases portable electronics insurance in a retail transaction. (Formerly SSB 1206.)
SF 347 (replaced by SF 563) – Iowa
Introduced: 2019 Status: In Process
A bill for an act relating to pharmacy benefit managers and health carriers and management of prescription drug benefits, and including applicability provisions. (See SF 563.)
SF 563 – Iowa
Introduced: 2019 Status: In Process
A bill for an act relating to pharmacy benefit managers and health carriers and management of prescription drug benefits, and including applicability provisions. (Formerly SF 347.) Senate File 563 creates two new chapters in the …
Next | See all Legislation Records
Introduced: 2019 Status: In Process
A bill for an act relating to the disclosure of the prices charged for health services rendered by health care providers and hospitals.
HF 605 – Iowa
Introduced: 2019 Status: In Process
A bill for an act relating to insurance notices and documents delivered by electronic means to a consumer that purchases portable electronics insurance in a retail transaction. (Formerly HSB 182.)
SF 559 – Iowa
Introduced: 2019 Status: In Process
A bill for an act relating to insurance notices and documents delivered by electronic means to a consumer that purchases portable electronics insurance in a retail transaction. (Formerly SSB 1206.)
SF 347 (replaced by SF 563) – Iowa
Introduced: 2019 Status: In Process
A bill for an act relating to pharmacy benefit managers and health carriers and management of prescription drug benefits, and including applicability provisions. (See SF 563.)
SF 563 – Iowa
Introduced: 2019 Status: In Process
A bill for an act relating to pharmacy benefit managers and health carriers and management of prescription drug benefits, and including applicability provisions. (Formerly SF 347.) Senate File 563 creates two new chapters in the …
Next | See all Legislation Records
Pharmaceutical Care Management v. Rutledge – Arkansas
District Court: Eastern District of Arkansas Status: Decided
The 8th Circuit held that both ERISA and Medicare Part D preempted Arkansas’ drug pricing law Act 900 (SB 688). Act 900 requires disclosure of …
PhRMA v. David – California
District Court: Eastern District of California Status: Pending
PhRMA is challenging California’s drug price transparency law SB 17 alleging that the law is unconstitutional because it violates the Commerce Clause, the First Amendment, …
Association for Accessible Medicines v. Frosh – Maryland
District Court: District of Maryland Status: Decided
In a significant victory for the pharmaceutical industry, the 4th U.S. Circuit Court of Appeals found Maryland’s landmark 2017 law (HB 631), which punishes generic …
PhRMA and BIO v. Sandoval – Nevada
District Court: District of Nevada Status: Decided
In September 2017, just three months after Nevada passed its insulin transparency law (SB 539) in June 2017 to increase transparency over the price of …
See all Litigation Records
District Court: Eastern District of Arkansas Status: Decided
The 8th Circuit held that both ERISA and Medicare Part D preempted Arkansas’ drug pricing law Act 900 (SB 688). Act 900 requires disclosure of …
PhRMA v. David – California
District Court: Eastern District of California Status: Pending
PhRMA is challenging California’s drug price transparency law SB 17 alleging that the law is unconstitutional because it violates the Commerce Clause, the First Amendment, …
Association for Accessible Medicines v. Frosh – Maryland
District Court: District of Maryland Status: Decided
In a significant victory for the pharmaceutical industry, the 4th U.S. Circuit Court of Appeals found Maryland’s landmark 2017 law (HB 631), which punishes generic …
PhRMA and BIO v. Sandoval – Nevada
District Court: District of Nevada Status: Decided
In September 2017, just three months after Nevada passed its insulin transparency law (SB 539) in June 2017 to increase transparency over the price of …
See all Litigation Records
News & Opinions
Articles & Reports
Annals of Internal Medicine April 2, 2019
Health Care Cost Institute March 28, 2019
United States Government Accountability Office March 21, 2019
NEJM Catalyst March 20, 2019
Health Care Cost Institute March 28, 2019
United States Government Accountability Office March 21, 2019
NEJM Catalyst March 20, 2019